Tobacco smoking and tobacco cessation in 2022
In a glimpse, OFDT, 2 p.
May 2023
This report from the French Monitoring Centre for Drugs and Drug Addiction (OFDT) provides an overview of the supply, uses, and the social and health consequences of the use of tobacco in France in 2022. The data are compared with those for the period 2017-2022, in order to cover the entire period covered by the National Tobacco Control Program from 2018 to 2022.
The first part focuses on changes in the tobacco market, both legal (tobacconists’ network, purchases abroad, duty free, etc.) and illegal (smuggling, counterfeiting, etc.). The amounts sold through tobacconist networks amounted to 40 134 tonnes 2022. They fell by 6.3% compared with 2021 on an equivalent number of delivery days, and by 26.1% compared with 2017 (with a stronger trend in bordering departments: -33.2%).
The second section looks at changes in drug-related behaviour. Among adults, the latest data from the Santé publique France survey showed that 31.9% of people aged 18 to 75 said they smoked tobacco in 2021, including 25.3% on a daily basis. Daily and occasional use remained stable between 2019 and 2021, while use during the year increased slightly (30.4% in 2019). The OFDT’s ESCAPAD survey observed a significant decline in use among 17-year-olds in 2022, whatever the indicator considered.
Download In a glimpse, tobacco smoking and tobacco cessation in 2022 (295 Ko, 1p.)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
